Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cenovis Kids Superbiotics is a pediatric synbiotic dietary supplement marketed in South Korea that combines specific probiotic strains with prebiotic components to support gastrointestinal health and intestinal microbial balance in children. It is based on Probi Digestis, a clinically documented probiotic concept centered on the Lactobacillus plantarum 299v (DSM 9843) strain, and is formulated as a fast-melt, strawberry-flavored powder stick that can be poured directly into the mouth for convenient daily use in children roughly 4–10 years of age.[4][10] The product is positioned for general gut health benefits such as increasing beneficial lactic acid bacteria, suppressing harmful intestinal bacteria, facilitating bowel movements, and promoting overall intestinal health, rather than for treatment of a specific disease.[4][12] Cenovis Kids Superbiotics is commercialized by Sanofi’s Consumer Healthcare division under the Cenovis brand through a partnership with Swedish probiotic developer Probi, which supplies the Probi Digestis technology and strain.[4][10]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cenovis Kids Superbiotics.